A carregar...
Orphan Drug Pricing and Costs: A Case Study of Kalydeco and Orkambi
BACKGROUND: A common narrative is that high prices are necessary for “orphan drugs” because of the fewer patients. In the context of state health insurance systems, the high prices create significant challenges because of limited budgets. RESULTS: This study carefully examines both costs and revenue...
Na minha lista:
| Publicado no: | Healthc Policy |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Longwoods Publishing
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7008693/ https://ncbi.nlm.nih.gov/pubmed/31629457 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12927/hcpol.2019.25937 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|